Researchers find comparable long-term outcomes between diastolic and systolic heart failure patients

A new study by researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) found comparable long-term outcomes between congestive heart failure patients with preserved ejection fraction commonly known as "diastolic heart failure" and congestive heart failure with reduced ejection fraction also known as "systolic heart failure." The findings are published online in The American Journal of Cardiology.

Patients with normal percentage of blood leaving the heart each time it contracts and symptoms of are considered to have diastolic heart failure. Diastolic heart failure patients have not been as well studied as patients with . Systolic heart failure patients have impaired blood ejection with each contraction of the heart, and do not derive long term benefit from the same medications.

According to the researchers, heart failure affects six million people in the U.S. alone and half of those admissions are patients with diastolic heart failure. However, there are not yet any treatments for this condition. In addition, the number of people who will develop diastolic heart failure is expected to rise as the population ages and the incidence of obesity and hypertension increases.

"An incredible amount of expensive and time-consuming resources are being spent on reducing readmissions at a national level, but have not translated into a reduction in heart failure mortality," said senior author Flora Sam, MD, associate professor of cardiovascular medicine at the Whitaker Cardiovascular Institute at BUSM and attending physician of cardiovascular medicine and heart failure at BMC.

The researchers gathered patient data from all heart failure admissions over a two-year period at BMC. Using the American Heart Association's Get-With-the-Guidelines quality improvement program, patients were reviewed for co-morbid conditions including kidney function, blood counts, and blood tests such as brain natriuretic peptide (BNP), a marker of heart failure.

The findings showed that in comparison to those with systolic heart failure, diastolic heart failure patients were older, more likely to be overweight, female and have hypertension. The one-year outcome of in-hospital morbidity and mortality was similar between diastolic and systolic heart failure patients. Though the early readmission rate in the 30 days after discharge was initially lower in patients with diastolic heart failure, this soon increased such that it was similar to those with systolic heart failure.

"This study shows the importance of refocusing our attention and resources on medication trials, which have historically reduced adverse long-term outcomes in patients. Exploring medicinal treatment options for diastolic could potentially reduce readmissions, morbidity, mortality and long-term healthcare costs," said Sam.

add to favorites email to friend print save as pdf

Related Stories

Living better with heart failure by changing what you eat

Sep 24, 2013

Diet can dramatically lower hypertension and improve heart function in patients with a common type of heart failure, according to research presented at today's Heart Failure Society of America meeting in Orlando, Fla.

Patients with heart failure need specialist care

Nov 01, 2013

(Medical Xpress)—New research from Karolinska Institutet in Sweden shows that patients with heart failure have high mortality and often are undertreated. According to a study, published in the scientific periodical JACC, ...

Recommended for you

Appropriate use criteria established for pediatric ECHO

6 hours ago

(HealthDay)—Appropriate use criteria have been developed for the initial use of transthoracic echocardiography in outpatient pediatric cardiology. The guidelines were published online Sept. 29 in the Journal of ...

Fish oil supplements don't prevent recurrence of A-fib

Sep 30, 2014

(HealthDay)—High doses of fish oil supplements won't prevent recurrence of atrial fibrillation (AF), Canadian researchers report. The study, funded by the Canadian Institutes for Health Research and the ...

User comments